LT4069232T - Masupirdinas elgesio ir psichologinių simptomų, sergant demencija, gydymui - Google Patents
Masupirdinas elgesio ir psichologinių simptomų, sergant demencija, gydymuiInfo
- Publication number
- LT4069232T LT4069232T LTEPPCT/IB2020/061383T LTIB2020061383T LT4069232T LT 4069232 T LT4069232 T LT 4069232T LT IB2020061383 T LTIB2020061383 T LT IB2020061383T LT 4069232 T LT4069232 T LT 4069232T
- Authority
- LT
- Lithuania
- Prior art keywords
- masupirdine
- dementia
- psychological symptoms
- treating behavioral
- behavioral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201941049517 | 2019-12-02 | ||
| IN201941049516 | 2019-12-02 | ||
| PCT/IB2020/061383 WO2021111330A1 (en) | 2019-12-02 | 2020-12-02 | Treating behavioral and psychological symptoms in dementia patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT4069232T true LT4069232T (lt) | 2026-02-10 |
Family
ID=74003821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/IB2020/061383T LT4069232T (lt) | 2019-12-02 | 2020-12-02 | Masupirdinas elgesio ir psichologinių simptomų, sergant demencija, gydymui |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20220409614A1 (lt) |
| EP (1) | EP4069232B1 (lt) |
| JP (1) | JP7556031B2 (lt) |
| KR (1) | KR20220108123A (lt) |
| CN (1) | CN114901282B (lt) |
| AU (1) | AU2020398082A1 (lt) |
| BR (1) | BR112022010493A2 (lt) |
| CA (1) | CA3162952C (lt) |
| DK (1) | DK4069232T3 (lt) |
| FI (1) | FI4069232T3 (lt) |
| IL (1) | IL293416A (lt) |
| LT (1) | LT4069232T (lt) |
| MA (1) | MA57829B1 (lt) |
| MX (1) | MX2022006535A (lt) |
| PL (1) | PL4069232T3 (lt) |
| PT (1) | PT4069232T (lt) |
| RS (1) | RS67679B1 (lt) |
| SM (1) | SMT202600019T1 (lt) |
| WO (1) | WO2021111330A1 (lt) |
| ZA (1) | ZA202206042B (lt) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1581492B1 (en) | 2002-11-28 | 2008-07-16 | Suven Life Sciences Limited | N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| TW200531680A (en) | 2004-03-03 | 2005-10-01 | Merz Pharma Gmbh & Co Kgaa | Therapy using 1-aminocyclohexane derivatives for the treatment of behavioral disorders associated with alzheimer's disease |
| JP2014515408A (ja) * | 2011-06-03 | 2014-06-30 | エラン ファーマシューティカルズ，リミティド ライアビリティー カンパニー | 行動及び精神障害の治療のためのシロ−イノシトール |
| MX364930B (es) | 2013-12-02 | 2019-05-14 | Suven Life Sciences Ltd | Proceso de producción a gran escala de dimesilato de 1-[(2-bromofenil]sulfonil]-5-metoxi-3-[(4-metil-1-piperazinil)met il]-1h-indol monohidratado. |
| HUE050819T2 (hu) * | 2016-05-18 | 2021-01-28 | Suven Life Sciences Ltd | Tiszta 5-HT6 receptor antagonisták kombinációja acetilkolinészteráz inhibitorokkal |
| BR112018073396A2 (pt) * | 2016-05-18 | 2019-03-19 | Suven Life Sciences Limited | combinação de antagonistas, uso de uma combinação, método para o tratamento de desordens cognitivas, composto, método para o tratamento de doença de alzheimer e composição farmacêutica |
| SG11201809726UA (en) | 2016-05-18 | 2018-12-28 | Suven Life Sciences Ltd | Triple combination of pure 5-ht6 receptor antagonists, acetylcholinesterase inhibitors and nmda receptor antagonist |
| WO2019008484A1 (en) | 2017-07-03 | 2019-01-10 | Suven Life Sciences Limited | NEW USES OF A PURE 5-HT6 RECEPTOR ANTAGONIST |
-
2020
- 2020-12-02 SM SM20260019T patent/SMT202600019T1/it unknown
- 2020-12-02 IL IL293416A patent/IL293416A/en unknown
- 2020-12-02 MA MA57829A patent/MA57829B1/fr unknown
- 2020-12-02 BR BR112022010493A patent/BR112022010493A2/pt unknown
- 2020-12-02 KR KR1020227022173A patent/KR20220108123A/ko active Pending
- 2020-12-02 EP EP20829008.0A patent/EP4069232B1/en active Active
- 2020-12-02 LT LTEPPCT/IB2020/061383T patent/LT4069232T/lt unknown
- 2020-12-02 MX MX2022006535A patent/MX2022006535A/es unknown
- 2020-12-02 RS RS20260069A patent/RS67679B1/sr unknown
- 2020-12-02 CA CA3162952A patent/CA3162952C/en active Active
- 2020-12-02 CN CN202080090893.7A patent/CN114901282B/zh active Active
- 2020-12-02 DK DK20829008.0T patent/DK4069232T3/da active
- 2020-12-02 PL PL20829008.0T patent/PL4069232T3/pl unknown
- 2020-12-02 PT PT208290080T patent/PT4069232T/pt unknown
- 2020-12-02 FI FIEP20829008.0T patent/FI4069232T3/fi active
- 2020-12-02 WO PCT/IB2020/061383 patent/WO2021111330A1/en not_active Ceased
- 2020-12-02 AU AU2020398082A patent/AU2020398082A1/en active Pending
- 2020-12-02 US US17/780,734 patent/US20220409614A1/en active Pending
- 2020-12-02 JP JP2022532840A patent/JP7556031B2/ja active Active
-
2022
- 2022-05-31 ZA ZA2022/06042A patent/ZA202206042B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI4069232T3 (fi) | 2026-02-10 |
| MA57829B1 (fr) | 2026-02-27 |
| AU2020398082A1 (en) | 2022-06-16 |
| MX2022006535A (es) | 2022-09-09 |
| RS67679B1 (sr) | 2026-02-27 |
| EP4069232A1 (en) | 2022-10-12 |
| EP4069232B1 (en) | 2025-12-24 |
| DK4069232T3 (da) | 2026-01-26 |
| CA3162952C (en) | 2024-06-11 |
| BR112022010493A2 (pt) | 2022-09-06 |
| JP2023506724A (ja) | 2023-02-20 |
| SMT202600019T1 (it) | 2026-03-09 |
| PL4069232T3 (pl) | 2026-03-16 |
| CA3162952A1 (en) | 2021-06-10 |
| ZA202206042B (en) | 2024-09-25 |
| CN114901282A (zh) | 2022-08-12 |
| JP7556031B2 (ja) | 2024-09-25 |
| IL293416A (en) | 2022-07-01 |
| WO2021111330A1 (en) | 2021-06-10 |
| PT4069232T (pt) | 2026-01-26 |
| CN114901282B (zh) | 2024-06-25 |
| AU2020398082A8 (en) | 2022-07-28 |
| US20220409614A1 (en) | 2022-12-29 |
| KR20220108123A (ko) | 2022-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285649A (en) | Azepino-indoles and other heterocyclics for the treatment of brain disorders | |
| SG11202012903TA (en) | Methods and devices for reducing myopia in children | |
| PT3768118T (pt) | Métodos para dispor uma película de vedação superior num tabuleiro de cartão | |
| EP3801744A4 (en) | METHOD AND DEVICE FOR TREATING SLEEP-RELATED RESPIRATORY DISORDERS | |
| IL276247A (en) | Methods and materials for the treatment of sleep apnea | |
| GB201603952D0 (en) | Methods and apparatus for treating waste | |
| LT3903795T (lt) | Nervinio audinio vienetas ir tokio vieneto naudojimas implantuojant į žinduolio nervų sistemą | |
| IL276358A (en) | COMPOUNDS AND METHODS FOR THE TREATMENT OF ADDICTION AND RELATED DISORDERS | |
| EP3826684A4 (en) | METHODS OF TREATMENT OF DISEASES ASSOCIATED WITH ABNORMAL ACVR1 EXPRESSION AND ACVR1 INHIBITORS FOR USE IN THE SAME | |
| SG11202107842QA (en) | Methods for treating symptoms and disorders associated with lysosomal storage diseases | |
| IL276639A (en) | Materials and methods for the treatment of dysproliferative diseases | |
| IL282965A (en) | Electronic devices and treatment methods using antipsychotic drugs in combination with digital therapies | |
| SMT202600019T1 (it) | Masupirdina per il trattamento dei sintomi comportamentali e psicologici nella demenza | |
| GB2603060B (en) | Unit verification method and device | |
| GB2572055B (en) | Chute and method | |
| PT4069231T (pt) | Combinações de masupirdina com donepezilo ou memantina para tratamento de sintomas comportamentais e psicológicos em pacientes com demência | |
| SG10202005848TA (en) | Method for automatically validating cots and device for implementing the method | |
| GB2596685B (en) | Integrated milling and production device and method | |
| GB2591387B (en) | Waste treatment apparatus and method | |
| GB201807232D0 (en) | Database and associated method | |
| IL289331B1 (en) | Medicinal substance and method | |
| ZA202105162B (en) | System and method for the verification of medication | |
| HK40050297A (en) | Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same | |
| SG11202104661WA (en) | Composition and method for aiding sleep | |
| GB201701196D0 (en) | Method and apparatus for use in appraising a well structure |